Neutrophil extracellular traps block endogenous and intravenous thrombolysis-induced fibrinolysis in large vessel occlusion acute ischemic stroke
Rattachement africain : fr, ca. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Abstract Background Intravenous thrombolysis (IVT) failure in acute ischemic stroke (AIS) due to large vessel occlusion (LVO) is frequent but its causes remain elusive. Several non-exclusive mechanisms have been proposed to explain IVT failure, including failed delivery of tPA and inhibition of its activity. We investigated whether biologically relevant intrathrombus concentrations of t-PA were achieved in failed IVT in patients with LVO AIS, and whether neutrophil extracellular traps (NETs) contributed to IVT failure. Methods In this cohort study, a total of 205 thrombi from AIS patients with LVO were analyzed. 83 of these thrombi were compared for tPA content and 53 for their susceptibility to ex vivo thrombolysis according to IVT status. An additional subset of 69 AIS thrombi was used to decipher if and how NETs interfere with intrathrombus fibrinolysis. Results AIS thrombi from IVT patients contained more tPA than those from no-IVT patients (0.209 vs 0.093 µg/mg of thrombus, p<0.0001). Plasminogen and tPA in AIS thrombi were found in association with fibrin and NETs. The ability of NETs to bind tPA and plasminogen, titrating them away from fibrin, was confirmed in a microfluidic model of thrombosis. While ex vivo addition of plasminogen did not cause lysis of either no-IVT or IVT thrombi, combining plasminogen with DNase 1 helped translate the increased tPA content of IVT thrombi into increased thrombolysis. We further show that DNase 1 enables tPA- and plasmin-mediated thrombolysis by eliminating fibrinolysis inhibitors from AIS thrombi. Conclusions These results indicate that intrathrombus tPA concentrations reached in failed IVT bear a therapeutic potential that is however impaired by NETs, which favor intrathrombus retention of fibrinolysis inhibitors and compete with fibrin for tPA and plasminogen binding. Our results stress the interest of DNase 1 to enhance the efficacy of current IVT tPA regimens. Clinical Perspective What is new? Intravenous thrombolysis increases thrombus tPA content even when it fails to cause arterial recanalization in acute ischemic stroke The fibrinolytic activity of intravenously-administered tPA is blocked by neutrophil extracellular traps in acute ischemic stroke thrombi Neutrophil extracellular traps participate in thrombolysis resistance by retaining fibrinolysis inhibitors and titrating tPA and plasminogen away from fibrin in acute ischemic stroke thrombi DNase 1 can convert increased tPA content into increased fibrinolysis by eliminating NETs-associated fibrinolysis inhibitors in acute ischemic stroke thrombi 2) What are the clinical implications? Despite therapeutic failure, biologically significant intrathrombus tPA concentrations are achieved following intravenous thrombolysis at current tPA regimens Sequential administration of DNase 1 prior to intravenous thrombolysis could clear the way for tPA and potentiate its fibrinolytic activity for improved arterial recanalization efficacy
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Neutrophil extracellular traps block endogenous and intravenous thrombolysis-induced fibrinolysis in large vessel occlusion acute ischemic stroke
- Date Crossref
- 03/04/2025
- Éditeur
- openRxiv
- Type
- posted-content
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Inserm pays non établi dans la noticeOrganisme public
-
Université Paris Cité pays non établi dans la noticeUniversité ou école supérieure
-
Sorbonne Paris Cité pays non établi dans la noticeInstitution
-
Ontario Stroke Network pays non établi dans la noticeOrganisation à but non lucratif
-
Fondation de Rothschild pays non établi dans la noticeOrganisation à but non lucratif
-
Optimisation Thérapeutique en Neuropsychopharmacologie pays non établi dans la noticeStructure de recherche
-
Assistance Publique – Hôpitaux de Paris pays non établi dans la noticeÉtablissement de santé
-
Hôpital Lariboisière Department of Neurology pays non établi dans la noticeÉtablissement de santé
-
Laboratoire de Recherche Vasculaire Translationnelle pays non établi dans la noticeStructure de recherche
-
Université de Lille pays non établi dans la noticeUniversité ou école supérieure
-
Centre Hospitalier Universitaire de Lille pays non établi dans la noticeÉtablissement de santé
-
FHU Neurovasc pays non établi dans la noticeÉtablissement de santé
Inserm, Université Paris Cité et Sorbonne Paris Cité, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.